Article Information
PubMed
History
- Published online February 22, 2011.
Article Versions
- Latest version (January 17, 2011 - 06:09).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2011 Canadian Medical Association or its licensors
Author Information
- Alissa J. Wright, MD,
- Tara Gomes, MHSc,
- Muhammad M. Mamdani, PharmD MPH,
- John R. Horn, PharmD,
- David N. Juurlink, MD PhD⇓
- From the Departments of Medicine (Wright, Juurlink) and Health Policy, Management and Evaluation (Mamdani), University of Toronto, Toronto, Ont.; St. Michael’s Hospital, Applied Health Research Centre, Li Ka Shing Knowledge Institute (Mamdani), Toronto, Ont.; the Departments of Pharmacy and Pharmacy Services (Horn), University of Washington, Seattle, Wash.; the Sunnybrook Research Institute (Juurlink), Toronto, Ont.; and the Institute for Clinical Evaluative Sciences (Mamdani, Gomes, Juurlink), Toronto, Ont.
- Correspondence to:
Dr. David Juurlink, dnj{at}ices.on.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Jump to section
Related Articles
Cited By...
- Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
- Revisiting the drug interaction between tamoxifen and SSRI antidepressants
- Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
- The cardiovascular safety of azithromycin
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
- Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics
More in this TOC Section
Similar Articles
